Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0598853 (
forgetting
)
3,232
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We compared 13 patients with dementia of the Alzheimer's type (DAT) and 9
progressive supranuclear palsy
(
PSP
) patients, matched by age, sex, education, and the overall level of cognitive deterioration, measured by using the Dementia Rating Scale, and 12 normal controls. The results of this study confirm that the pattern of cognitive deterioration of
PSP
patients differs from that of DAT patients. While episodic memory is severely affected early in the course of DAT, it appears to be relatively spared in
PSP
. In contrast to previous suggestions, we found no evidence for differentially rapid
forgetting
in DAT, although we did confirm relatively preserved recognition memory in
PSP
. We had predicted that the performance of the DAT group on tests of semantic memory (the Boston Naming Test, the ADA Synonym Judgement Test, and the Pyramids and Palm Trees Test) would be worse than that of the
PSP
group. However, there was, in fact, no difference on any of these measures, except that the
PSP
patients showed a significantly greater deficit on the Synonym Judgement Test. We suggest that the underlying cause of the semantic memory impairment might, however, be different in the two pathologies.
...
PMID:Episodic and semantic memory in Alzheimer's disease and progressive supranuclear palsy: a comparative study. 765 Jan 7
To test the hypothesis that memory disorders of subcortico-frontal dementia result mainly from inefficiency of retrieval processes of stored information, we compared verbal learning in 15 patients with
progressive supranuclear palsy
, prototypical of "subcortical dementia," in free (California Verbal Learning Test) and controlled (Grober and Buschke's Test) encoding situations, with that of 19 controls, matched for age and level of education. The
progressive supranuclear palsy
patients showed memory deficits characterized by impaired immediate memory span, disturbed learning and consistency of recall, and abnormal number of false alarms at recognition, which were dramatically alleviated by controlled encoding associated with cued recall, using the same semantic cues. This memory profile was markedly different from that of patients with senile dementia of the Alzheimer type (n = 15), characterized by more rapid
forgetting
and less improvement in the controlled situation. Instead, it was similar to the memory pattern of patients with Parkinson's (n = 15) and Huntington's (n = 15) diseases. These results show a similar profile of memory disturbance in disorders involving damage to the striatofrontal system and suggest that the cortical and hippocampal lesions of
PSP
patients are insufficiently severe to interfere with the specific memory profile characteristic of the disease.
...
PMID:Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases. 803 27
Progressive supranuclear palsy
(
PSP
) is the epitome of a subcortical dementia process. Due to its relative rarity, there is only a small literature on the neuropsychological consequences of
PSP
. The findings to date demonstrate that
PSP
patients have dramatically slowed information processing and motor execution, rapid
forgetting
, problems in orienting attentional resources, and difficulty in planning and shifting conceptual sets. The pattern and severity of these deficits are unique to
PSP
and suggest that the study of
PSP
patients can provide a special insight into brain-behavior relations.
...
PMID:Neuropsychological features of progressive supranuclear palsy. 854 57